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Abstract
Ageing is associated with reduced appetite and energy intakes. However, the mechanisms underlying this phenomenon 
are not fully understood. This systematic review and meta-analysis quantified differences in circulating concentrations of 
appetite-related hormones between healthy older and younger adults. Six databases were searched through 12th June 2018 
for studies that compared appetite-related hormone concentrations between older and younger adults. Data were pooled using 
random-effects meta-analysis and are presented as standardised mean difference (Hedges’ g) with 95% confidence intervals 
(95% CI). Thirty-five studies were included involving 710 older adults (mean ± SD; age: 73 ± 5 years) and 713 younger adults 
(age: 28 ± 7 years). Compared with younger adults, older adults exhibited higher fasted and postprandial concentrations of 
the anorectic hormones cholecystokinin (Fasted: SMD 0.41 (95% CI 0.24, 0.57); p < 0.001. Postprandial: SMD 0.41 (0.20, 
0.62); p < 0.001), leptin [Fasted: SMD 1.23 (0.15, 2.30); p = 0.025. Postprandial: SMD 0.62 (0.23, 1.01); p = 0.002] and 
insulin [Fasted: SMD 0.24 (− 0.02, 0.50); p = 0.073. Postprandial: SMD 0.16 (0.01, 0.32); p = 0.043]. Higher postprandial 
concentrations of peptide-YY were also observed in older adults compared with younger adults [SMD 0.31 (− 0.03, 0.65); 
p = 0.075]. Compared with younger adults, older adults had lower energy intakes [SMD − 0.98 (− 1.74, − 0.22); p = 0.011], 
and lower hunger perceptions in the fasted [SMD − 1.00 (− 1.54, − 0.46); p < 0.001] and postprandial states [SMD − 0.31, 
(− 0.64, 0.02); p = 0.064]. Higher circulating concentrations of insulin, leptin, cholecystokinin and peptide-YY accord with 
reduced appetite and energy intakes in healthy older adults. Interventions to reduce circulating levels of these hormones may 
be beneficial for combatting the anorexia of ageing.
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Introduction
Currently, 962 million people worldwide are over the age 
of 60 years [1] and it is predicted that 22% of the global 
population will be 60 years and older by 2050 [2]. A high 
proportion of health care is spent on older adults and this 
is set to increase given the projected rise in this population. 
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Therefore, improving health in older adults is a crucial pub-
lic health priority.
The “anorexia of ageing” describes a reduction in appe-
tite and energy intake in older adults. Current observations 
suggest that this phenomenon has a prevalence of 15–30% 
in independently living older adults, with higher incidence 
occurring in hospital and nursing home settings [3]. The 
anorexia of ageing represents an independent risk factor for 
frailty, incident disability, morbidity and mortality [3–5]. 
Consequently, developing a better understanding of the 
mechanisms underlying the anorexia of ageing is important 
in designing interventions to prevent further deterioration 
in quality of life.
Appetite is regulated physiologically by the neuroen-
docrine system [6], with multiple hormones implicated as 
mediators of hunger and satiety. Several hormones have 
been identified to exert appetite-suppressing effects, includ-
ing peptide-YY (PYY), glucagon-like-peptide-1 (GLP-1), 
oxytomodulin, pancreatic polypeptide (PP), cholecysto-
kinin (CCK), gastric inhibitory peptide (GIP), insulin and 
leptin. Alternatively, ghrelin represents the only peripheral 
peptide known to exert an orexigenic effect [6, 7]. Current 
research suggests that changes in appetite-related hormones 
may mediate the reductions in appetite and energy intake 
observed in older adults. However, conclusions are yet to 
be drawn due to inconsistent findings between studies, likely 
due to differences in methodologies and the hormones meas-
ured. For example, results from Giezenaar et al. [8] demon-
strated higher plasma concentrations of CCK in older adults 
compared with younger adults; however, these concentra-
tions did not differ between older and younger adults in the 
study of Winkels et al. [9].
A systematic evaluation of the literature is required 
to gain a clear understanding of which hormones exhibit 
altered concentrations between older and younger adults, as 
well as the direction and size of any effects. Thus, the pur-
pose of this research was to provide a systematic review and 
meta-analysis of studies which compared circulating appe-
tite-related hormone concentrations between metabolically 
healthy older and younger adults in the fasted and/or post-
prandial state, with no known co-morbidities or pre-existing 
medical conditions. Comparisons of appetite perceptions 
and energy intake between the groups were also included 
where available. Understanding these effects contributes to 
the identification of potential mechanistic targets for future 
interventions to reduce the anorexia of ageing.
Methods
This systematic review and meta-analysis was performed in 
accordance with the preferred reporting items for systematic 
review and meta-analyses (PRISMA) guidelines [10] and 
was prospectively registered with the PROSPERO database 
(CRD42017083747).
Literature search
PubMed and The Cochrane Library as well as MEDLINE, 
SPORTDiscus, PsycINFO and CINAHL, via EBSCOhost, 
were searched in December 2017, with an updated search 
on 12th June 2018. These databases were used to provide a 
thorough approach for searches to obtain the maximum num-
ber of relevant studies, including relevant data from stud-
ies in which exercise or psychological interventions were 
implemented. Keyword searches were based on the popula-
tion (i.e., older adults) in combination with appetite-related 
hormones, and appetite perceptions and/or energy intake. 
The specific keywords and the full search strategy can be 
found in supplementary material 1. The search strategy pro-
vided a total of 328 combinations. Reference lists of eligible 
studies and review articles were also hand searched. If only 
the abstract or partial data were published, then the author 
was contacted for the full data set. No language or date of 
publication restrictions were applied during the searches.
Inclusion criteria
For inclusion, studies were required to meet the following 
criteria; participants in the study were not noted to be smok-
ers, pregnant, or have a history of diabetes, gastrointesti-
nal, inflammatory, metabolic, cardiovascular, neurological 
or psychological disease(s). Studies were excluded if there 
was evidence to show the implementation of a diet to induce 
energy imbalance, the administration of a supplement or tak-
ing medication as this is shown to affect appetite. Studies 
which investigated participants under the age of 18 were 
excluded. Studies were included if they were published in 
peer-reviewed journals, or were available as published con-
ference proceedings, theses or dissertations to minimise the 
effect of any potential publication bias.
All studies were required to contain at least one of the 
following measures of circulating appetite-related hormone 
concentrations: leptin, acylated ghrelin, total ghrelin, oxyn-
tomodulin, PYY, GLP-1, PP, GIP, CCK and/or insulin, in 
distinct groups of older and younger adults within the same 
study. Any postprandial comparisons of appetite-related 
hormone concentrations where < 125 kJ was provided dur-
ing feeding were excluded from the analysis. Studies which 
involved the infusion of a nutrient as the feeding interven-
tion were included, however, studies involving the infusion 
of pharmacological products were excluded. In addition to 
these outcomes, appetite perceptions and/or energy intake 
data were extracted if provided in the included studies.
Two researchers (KJ and OS) independently assessed 
titles and abstracts of studies for inclusion and later 
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compared notes to reach a mutual consensus. Research-
ers were not blinded to the articles. However, research 
has shown that blinding during study selection and data 
extraction had neither a clinically nor a statistically signifi-
cant effect on the summary outcome [11]. Disagreements 
about the eligibility of any particular studies were resolved 
by a third reviewer (KD). Potential studies that could be 
included based on their title or abstract were retrieved in 
full text and reviewed against the inclusion/exclusion cri-
teria independently by two researchers (KJ and OS) with a 
third researcher (KD) used to settle any disputes. In total, 
35 studies met the inclusion criteria and were included in 
this meta-analysis (see flow chart in supplementary figure 1). 
For a variable to be included in the meta-analysis, a mini-
mum of three studies measuring the respective variable were 
required to meet the inclusion criteria.
Data abstraction
Data were extracted independently by two separate research-
ers (KJ and OS) into a standardised spreadsheet which 
included (1) characteristics of articles valid for review; (2) 
the critical appraisal tool to assess the quality of cross-sec-
tional studies (AXIS) (3) outcome data suitable for succes-
sive analysis based on mean, SD and sample size. Research-
ers were not blinded to articles during this process, however, 
risk of bias can be effectively conducted under blinded con-
ditions [12]. Additional data were collected for study design, 
participant characteristics, the duration of observations and 
number of blood samples taken, hormone analytical method, 
as well as the assessment method of energy intake.
Where values were only presented in figure form, authors 
were contacted to provide the full dataset. If the dataset 
could not be retrieved (n = 17) the figure was digitised 
using graph digitiser software (DigitizeIt, Germany) and the 
means and SD/SEM were measured manually at the pixel 
level to the scale provided on the figure. DigitizeIt has been 
shown to provide valid and reliable results which provide 
good agreement with raw data values [13]. If area under the 
curve values were reported rather than the mean values, the 
mean values were calculated by dividing the area under the 
curve scores by time duration.
Study appraisal and quality assessment
The critical appraisal tool to assess the quality of cross-
sectional studies (AXIS) [14] was independently assessed 
by two reviewers (KJ and OS). Each included study was 
systematically evaluated against a 17-item checklist to 
judge study quality and the possibility of bias. Review-
ers answered “yes” or “no” to each question within the 
checklist. When insufficient detail was reported, the 
reviewers answered the question with “do not know”. 
Disagreements were initially resolved via discussion 
between two independent reviewers (KJ and OS), how-
ever, a third reviewer (KD) was consulted for any neces-
sary dispute resolution. Due to the cross-sectional nature 
of study designs within this meta-analysis, questions 7, 
13 and 14 were removed with regard to addressing non-
responders. Studies were not excluded based on the results 
of the quality assessment, however, for transparency, the 
quality of included studies has been presented in supple-
mentary table 26.
Statistical analysis
Missing standard deviations were calculated from stand-
ard errors or confidence intervals (CI). Outcome meas-
ures were converted into the standardised mean difference 
(SMD) and expressed as Hedges’ g with 95% CI which 
were used as the summary statistic. Correction using 
Hedges’ g is believed to yield an unbiased estimate of 
effect size [15]. The SMD represents the size of the differ-
ence between groups relative to the variability observed in 
the groups. A random-effects meta-analysis was performed 
by KJ and KD using Comprehensive Meta-Analysis Soft-
ware (version 3, Biostat, Englewood, NJ, USA). A ran-
dom-effects model was employed for all analyses based 
on the assumption that heterogeneity would exist between 
included studies due to the variability in study designs 
[16].The inputted data included sample sizes and outcome 
measures with their respective standard deviations.
Interpretation of SMD values was as follows: < 0.20 
as trivial, 0.20–0.39 as small, 0.40–0.80 as moderate and 
> 0.80 as large [17]. A positive ES value indicated that hor-
mone concentrations were higher in older adults compared 
with younger adults. Heterogeneity between trials was 
assessed using the I-squared statistic, where 0–40% sug-
gests heterogeneity might not be important, 30–60% may 
represent moderate heterogeneity, 50–90% may represent 
substantial heterogeneity and 75–100% represents substan-
tial heterogeneity [18]. This measure of heterogeneity was 
complimented by also reporting the Tau-squared statistic 
and the Chi squared statistic. To examine whether any 
conclusions were dependent on a single study, sensitivity 
analyses were employed for each variable by repeating the 
analysis with each study omitted in turn.
Where data were available, subgroup meta-analysis 
was performed for feeding method (infusion vs. eating), 
hormone analytical method (RIA vs. ELISA) and energy 
intake assessment method (researcher measured vs. self-
reported). Each subgroup was required to have a minimum 
of three studies.
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Exploration of small study effects
Small study effects were explored with funnel plots of SMD 
versus standard errors [19] and by quantifying Egger’s lin-
ear regression intercept. A large and statistically significant 
Egger’s statistic indicates the presence of small study effects.
Results
Overview
Supplementary figure 1 outlines the flowchart of study selec-
tion. In total, 35 studies met the inclusion criteria for the 
meta-analysis. All included studies had been published (or 
accepted for publication) in peer-reviewed scientific jour-
nals at the time of inclusion (see supplementary material 2 
for article references). Within the 35 studies, there were 31 
fasted and 25 postprandial comparisons that were included 
between older and younger adults. Comparisons were segre-
gated into fasted (see supplementary table 1) and postpran-
dial (see supplementary table 2) responses to differentiate 
between findings during these two distinct periods of appe-
tite regulation. Fasted comparisons represent single time 
points obtained after an overnight fast, whereas postpran-
dial comparisons represent means of multiple time points 
after feeding.
There were four studies that involved more than two age 
groups; consequently, the youngest and oldest age groups 
were extracted for these studies. Out of the 35 studies 
which assessed circulating appetite-related hormone con-
centrations, 11 compared energy intake between older and 
younger adults (supplementary table 3). One study obtained 
energy intake by the 24-hour recall method, six studies by 
ad libitum meals and four through food diaries lasting 3–5 
days. All studies which reported postprandial comparisons 
provided standardised meals or infusions to participants with 
an energy content of 502–4064 kJ (mean: 2454 kJ) and had 
hormone observation periods of 0.5–24 h (mean: 4.41 h). All 
studies involving postprandial comparisons provided mixed 
macronutrient meals, with 19 studies providing it in solid 
form, 6 studies involving the infusion of a nutrient, 2 studies 
providing it in liquid form and 1 study comparing both liquid 
and solid form. Three studies manipulated the macronutrient 
composition of the mixed meals to identify if this dictated 
postprandial outcomes. If a study contained more than one 
postprandial comparison for each age group, then the results 
were combined with the study being the unit for analysis. 
The effects of macronutrient manipulation were conflicting 
between studies, therefore, it is difficult to draw conclusions 
on the effects of macronutrient distribution on differences 
in appetite-related hormone concentrations between older 
and younger adults.
Hunger was assessed alongside appetite-related hormone 
concentrations in 13 out of the 35 studies, with 7 studies 
evaluating both fasted and postprandial responses, 5 studies 
reporting only fasted responses and 1 study only presenting 
postprandial hunger perceptions between older and younger 
adults (supplementary material 4).
Participant demographics
A total of 713 younger adults and 710 older adults were 
included in this meta-analysis. Gender was reported in 31 
out of 35 studies (532 men and 573 women; 48.1% men). 
Mean age ranged from 19 to 50 (mean: 28) years for younger 
adults. For older adults, all studies ranged from 65 to 85 
(mean: 73) years. Mean BMI was reported in 25 out of 35 
studies and ranged from 21.2 to 28.1 (mean: 23.6) kg m−2 
for younger adults and 20.5–26.9 (mean: 24.8) kg m−2 for 
older adults, therefore falling in the healthy weight category 
for both groups.
Meta‑analysis
Individual study statistics and results for each outcome vari-
able are summarised in supplementary tables 5–22.
Standardised mean difference for acylated ghrelin 
concentrations
Only one study which met the inclusion criteria included the 
measurement of circulating acylated ghrelin concentrations 
in the fasted state. Consequently, this could not be included 
in the meta-analysis.
Postprandial acylated ghrelin concentrations were lower 
in older adults than younger adults, with a small difference 
between groups (SMD: − 0.21, 95% CI: − 0.76 to 0.35; n = 5; 
p = 0.466; supplementary figure 2). The degree of heteroge-
neity may be moderate between studies (I2 = 52.6%; Q = 8.4, 
τ2 = 0.208, df = 4).
Standardised mean difference for total ghrelin 
concentrations
There was little difference in fasted total ghrelin concen-
trations when comparing older adults with younger adults 
(SMD: 0.13, 95% CI: − 0.12 to 0.39; n = 6; p = 0.312; sup-
plementary figure 3a). The degree of heterogeneity was 
found to be low between studies (I2 = 0.00%; Q = 5.0, 
τ2 < 0.0005, df = 5).
There was little difference in postprandial total ghrelin 
concentrations when comparing older adults with younger 
adults (SMD: 0.17, 95% CI: − 0.06 to 0.40; n = 8; p = 0.146; 
supplementary figure 3b). The degree of heterogeneity 
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was found to be low between studies (I2 =0.0%, Q = 2.8, 
τ2 < 0.0005, df = 7).
Standardised mean difference for CCK 
concentrations
Fasted CCK concentrations were higher in older adults 
than younger adults with a moderate difference between 
groups (SMD: 0.41, 95% CI: 0.24 to 0.57; n = 9; p < 0.0005; 
Fig. 1a). The degree of heterogeneity was found to be low 
between studies (I2= 0.0%, Q = 7.6, τ2 < 0.0005, df = 8).
Postprandial CCK concentrations were higher in older 
adults than younger adults with a moderate difference 
between groups (SMD: 0.41, 95% CI: 0.20–0.62, n = 8; 
p < 0.0005; Fig. 1b). The degree of heterogeneity was found 
to be low between studies (I2= 7.2%, Q = 7.5, τ2 = 0.085, 
df = 7).
Standardised mean difference and moderator 
variables for GLP‑1 concentrations
There was little difference in fasted GLP-1 concentrations 
when comparing older adults with younger adults (SMD: 
− 0.02, 95% CI: − 0.44 to 0.40; n = 7; p = 0.942; supple-
mentary figure 4a). The degree of heterogeneity may be 
substantial between studies (I2=75.8%; Q = 24.8, τ2 = 0.235 
and df = 6).
There was little difference in postprandial GLP-1 concen-
trations when comparing older adults with younger adults 
(SMD: 0.11, 95% CI: − 0.19 to 0.41; n = 7; p = 0.474; sup-
plementary figure 4b). The degree of heterogeneity was 
found to be moderate between studies (I2=48.7%, Q = 11.7, 
τ2 = 0.078, df = 6).
Standardised mean difference for leptin 
concentrations
Fasted leptin concentrations were higher in older adults 
than younger adults with a large difference between groups 
(SMD: 1.23, 95% CI: 0.15 to 2.30; n = 9; p = 0.025; Fig. 2a). 
The degree of heterogeneity was found to be considerable 
between studies (I2=96.7%, Q = 238.9, τ2 = 2.545, df = 8).
Postprandial leptin concentrations were higher in 
older adults than younger adults with a moderate differ-
ence between groups (SMD: 0.62, 95% CI: 0.23 to 1.01; 
n = 7; p = 0.002; Fig. 2b). The degree of heterogeneity was 
found to be moderate between studies (I2=51.5%, Q = 12.4, 
τ2 = 0.138, df = 6).
Standardised mean difference and moderator 
variables for insulin concentrations
Fasted insulin concentrations were higher in older adults 
than younger adults with a small difference between groups 
(SMD: 0.24, 95% CI: − 0.02 to 0.50; n = 19; p = 0.073; 
Fig. 3a) The degree of heterogeneity may be substantial 
between studies (I2=74.3%, Q = 70.1, τ2 = 0.225, df = 18). 
Subgroup analysis revealed no significant effect of the hor-
mone analytical method on outcomes (p = 0.99; Table 1).
There was a trivial but significant difference in post-
prandial insulin concentrations between younger and older 
adults (SMD: 0.16, 95% CI: 0.01 to 0.32, n = 17; p = 0.043; 
Fig. 3b).The degree of heterogeneity was found to be low 
between studies (I2= 10.5%, Q = 17.9, τ2 = 0.001, df = 17).
Subgroup analysis revealed no significant effect of the hor-
mone analytical method or feeding method on outcomes 
(both p > 0.42; Table 1).
Fig. 1  Forest plot of standardised mean differences (means ± 95% 
confidence intervals [CIs] for studies evaluating the differences in 
fasted CCK concentrations (a) and postprandial CCK concentrations 
(b) in older versus younger adults. The size of each square represents 
the relative weight of each comparison. The diamond represents the 
SMD (mean ± 95% CI) for the model
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Standardised mean difference for PYY 
concentrations
Fasted PYY concentrations were lower in older adults than 
younger adults with a small difference between groups 
(SMD: − 0.35, 95% CI: − 1.10 to 0.40, n = 4; p = 0.357; 
Fig. 4a). The degree of heterogeneity may be substantial 
between studies (I2=77.7%, Q = 13.4, τ2 = 0.445, df = 3).
Postprandial PYY concentrations were higher in older 
adults than younger adults with a small difference between 
groups (SMD: 0.31, 95% CI: − 0.03 to 0.65; n = 4; p = 0.075; 
Fig. 4b). The degree of heterogeneity was found to be low 
between studies (I2= 0.0%, Q = 2.0, τ2 < 0.0005, df = 3).
Standardised mean difference and moderator 
variables for GIP concentrations
Fasted GIP concentrations were higher in older adults than 
younger adults with a small difference between groups 
(SMD: 0.16, 95% CI: − 0.23 to 0.54, n = 4; p = 0.334; sup-
plementary figure 5a). The degree of heterogeneity was 
Fig. 2  Forest plot of standardised mean differences (means ± 95% 
confidence intervals [CIs] for studies evaluating the differences in 
fasted leptin concentrations (a) and postprandial leptin concentrations 
(b) in older versus younger adults. The size of each square represents 
the relative weight of each comparison. The diamond represents the 
SMD (mean ± 95% CI) for the model
Fig. 3  Forest plot of standardised mean differences (means ± 95% 
confidence intervals [CIs] for studies evaluating the differences in 
fasted insulin concentrations (a) and postprandial insulin concentra-
tions (b) in older versus younger adults. The size of each square rep-
resents the relative weight of each comparison. The diamond repre-
sents the SMD (mean ± 95% CI) for the model
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found to be substantial between studies (I2= 63.8%, Q = 8.3, 
τ2 = 0.102, df = 3).
Postprandial GIP concentrations were higher in older 
adults than younger adults with a small difference between 
groups (SMD: 0.25, 95% CI: − 0.19 to 0.70; n = 4; p = 0.263; 
supplementary figure 5b). The degree of heterogeneity was 
found to be substantial between studies (I2 = 68.3%, Q = 9.5, 
τ2 = 0.140, df = 3).
Standardised mean difference and moderator 
variables for energy intake
Energy intake was lower in older adults than younger adults 
with a large difference between groups (SMD: − 0.98, 95% 
CI: − 1.74 to − 0.22; n = 11; p = 0.011; Fig. 5). The degree 
of heterogeneity is substantial between studies (I2 = 94.6%; 
Q = 186.1, τ2 = 1.455, df = 10).). Subgroup analysis revealed 
a difference in energy intake between assessment types 
(p = 0.015), with older adults only showing a significantly 
lower energy intake compared with younger adults when 
assessed via self-report methods (Table 1).
Table 1  Summary of moderator 
variable analysis for energy 
intake, GLP-1 and insulin by 
subgroup
Moderator Variable p value Comparison
Hormone analytical method
Fasted insulin 0.985 RIA (n = 10; SMD 0.26, 95% CI − 0.03 to 0.55)
ELISA (n = 7; SMD 0.22, 95% CI − 0.35 to 0.80)
Postprandial insulin 0.438 RIA (n = 7; SMD 0.34, 95% CI 0.07 to 0.60)
ELISA (n = 7; SMD 0.06, 95% CI − 0.19 to 0.31)
Type of feeding
Postprandial insulin 0.427 Infusion (n = 3; SMD 0.01, 95% CI − 0.41 to 0.44)
Feeding (n = 14; SMD 0.20, 95% CI 0.03 to 0.37)
Postprandial GLP-1 0.296 Feeding (n = 3; SMD 0.30; 95% CI − 0.12 to 0.73)
Infusion (n = 4; SMD − 0.01, 95% CI − 0.41 to 0.39)
Energy intake assessment method
Energy intake 0.015 Researcher measured (n = 7; SMD − 0.10, 95% CI 
− 0.88 to 0.68)
Self-report (n = 4; SMD − 2.89, 95% CI − 4.99 to 
− 0.78)
Fig. 4  Forest plot of standardised mean differences (means ± 95% 
confidence intervals [CIs] for studies evaluating the differences in 
fasted PYY concentrations (a) and postprandial PYY concentrations 
(b) in older versus younger adults. The size of each square represents 
the relative weight of each comparison. The diamond represents the 
SMD (mean ± 95% CI) for the model
Fig. 5  Forest plot of standardised mean differences (means ± 95% 
confidence intervals [CIs] for studies evaluating the differences in 
energy intake in older versus younger adults. The size of each square 
represents the relative weight of each comparison. The diamond rep-
resents the SMD (mean ± 95% CI) for the model
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Standardised mean difference for hunger score
Fasted hunger scores were lower in older adults than 
younger adults with a moderate difference between 
groups (SMD: − 1.00, 95% CI: − 1.54 to − 0.46; n = 12; 
p = 0.0003; Fig. 6a). The degree of heterogeneity may 
be substantial between studies (I2= 76.1%; Q = 46.1, 
τ2 = 0.671, df = 11).
Postprandial hunger scores were lower in older adults 
than younger adults with a small difference between 
groups (SMD: − 0.31, 95% CI: − 0.64 to 0.02; n = 8; 
p = 0.064; Fig.  6b). The degree of heterogeneity may 
be moderate between studies (I2 = 37.7%; Q = 11.2, 
τ2 = 0.082, df = 7).
Sensitivity analysis
Out of the 18 variables assessed in the meta-analysis, 11 
variables revealed only minor changes when one study 
was omitted in turn from each analysis. The remaining 
seven variables revealed the removal of one or more com-
parison causing significant changes to the SMD (supple-
mentary tables 23–25).
Egger’s regression
5 out of the 18 variables assessed in the meta-analysis 
demonstrated some evidence of small study effects after 
inspection of the funnel plot and Egger’s regression inter-
cept (see supplementary tables 23–25). The remainder of 
variables provided little evidence of small study effects.
Quality assessment
The quality of studies appeared to vary. Most studies met 
more than 8 of the quality criteria items out of a possible 
17 [mean (SD): 11 (2)]. All studies used the appropriate 
measurements to conduct assessment on appetite-related 
hormone concentrations. This included ELISA, RIA and 
standard chemiluminescent immunometric assays. The 
majority of studies included information regarding attain-
ing ethical approval. However, the majority of studies failed 
to justify the sample size used or provide evidence for a 
power calculation. Some studies also lacked information on 
sources of recruitment and whether the sample represented 
the population investigated (Table 2). Reviewer evaluations 
matched on 88–100% of questions for each study. Since 
studies compared the difference between older and younger 
adults, the criteria regarding non-responders were not rel-
evant (supplementary table 26).
Discussion
Understanding differences in appetite-related hormone 
concentrations between older and younger adults provides 
mechanistic insight into the effect of ageing on the appetite-
regulatory system. This systematic review and meta-analysis 
revealed higher fasted and postprandial circulating concen-
trations of CCK, insulin and leptin in older adults. We also 
observed higher postprandial concentrations of PYY in older 
versus younger adults. These findings were concomitant 
with reduced hunger and energy intake in older adults, which 
is in accordance with the anorectic effects of these hormones 
[6]. Alternatively, there were no clear differences between 
Fig. 6  Forest plot of standardised mean differences (means ± 95% 
confidence intervals [CIs] for studies evaluating the differences in 
fasted hunger (a) and postprandial hunger (b) in older versus younger 
adults. The size of each square represents the relative weight of each 
comparison. The diamond represents the SMD (mean ± 95% CI) for 
the model
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older and younger adults for circulating concentrations of 
GLP-1, GIP, total ghrelin and acylated ghrelin. The results 
from the present study suggest even without the presence of 
known metabolic diseases or co-morbidities, older adults 
experience alterations in appetite regulation.
The increase in CCK observed in the present review sup-
ports previous speculation that CCK signalling is increased 
during ageing. Indeed, the anorectic effects from elevated 
concentrations of CCK in the fasted and postprandial state 
may even be enhanced in older adults due to increased sen-
sitivity to the actions of this hormone [20, 21] via CCK1 
receptors on the nucleus of the solitary tract and vagal sig-
nalling [22]. In the postprandial state, CCK is released from 
the intestine in response to nutrients in the intestinal lumen 
and appears to be, at least partly, responsible for meal termi-
nation [23]. In addition to increased fasted satiating signals 
to the vagal nerve, increased circulating CCK also delays the 
rate of gastric emptying which is commonly seen in older 
adults. It has been suggested that delays in gastric emptying 
in older adults could reflect increased small intestinal feed-
back as a result of increased sensitivity and/or exposure of 
small intestine receptors to CCK [24]. Elevated postprandial 
concentrations and signalling of CCK may play a further 
role in enhanced satiation in combination with reductions 
in the gastric emptying rates of older adults.
The most robust differences between older and younger 
adults in the current review were observed for circulating 
concentrations of leptin, which were higher in older adults 
in both the fasted and postprandial state, with a large and 
moderate effect size, respectively. Leptin is an anorectic 
hormone secreted by adipose tissue [25] and therefore cir-
culates in proportion to body fat stores as a tonic regulator 
of energy balance [26]. Consequently, the higher levels of 
leptin in older adults may be due to greater adiposity. How-
ever, adiposity is unlikely to be the sole mechanism for these 
elevations in leptin, as Zamboni et al. [27] demonstrated that 
Table 2  Criteria for quality assessment and number (%) of studies scoring points for each criterion
Studies fulfilling the criteria, n (%)
Yes No Don’t know
Criteria
1 Were the aims/objectives of the study clear? 21 (52.5) 19 (47.5) 0 (0.0)
Methods
2 Was the study design appropriate for the stated aim(s)? 34 (85.0) 5 (12.5) 1 (2.5)
3 Was the sample size justified? 4 (10.0) 36 (90.0) 0 (0.0)
4 Was the target/reference population clearly defined? (is it clear who the research was about?) 26 (65.0) 12 (30.0) 2 (5.0)
5 Was the sample frame taken from an appropriate population base so that it closely represented the 
target/reference population under investigation?
12 (30.0) 3 (7.5) 25 (62.5)
6 Was the selection process likely to select subjects/participants that were representative of the target/
reference population under investigation?
9 (22.5) 5 (5.0) 26 (65.0)
7 Were measures undertaken to address and categorise non-responders? – – –
8 Were the risk factor and outcome variables measured appropriate to the aims of the study? 37 (92.5) 3 (7.5) 0 (0.0)
9 Were the risk factor and outcome variables measured correctly using instruments/measurements that 
had been trialled, piloted or published previously?
40 (100.0) 0 (0.0) 0 (0.0)
10 Is it clear what was used to determined statistical significance and/or precision estimates? (e.g., p 
values, confidence intervals)
27 (67.5) 13 (32.5) 0 (0.0)
11 Were the methods (including statistical methods) sufficiently described to enable them to be repeated? 20 (50.0) 20 (50.0) 0 (0.0)
Results
12 Were the basic data adequately described? 23 (57.5) 17 (42.5) 0 (0.0)
13 Does the response rate raise concerns about non-response bias? – – –
14 If appropriate, was information about non-responders described? – – –
15 Were the results internally consistent? 32 (80.0) 7 (17.5) 1 (2.5)
16 Were the results presented for all the analyses described in the methods? 30 (75.0) 10 (25.0) 0 (0.0)
Discussion
17 Were the authors’ discussions and conclusions justified by the results? 29 (72.5) 11 (27.5) 0 (0.0)
18 Were the limitations of the study discussed? 21 (52.5) 19 (47.5) 0 (0.0)
Other
19 Were there any funding sources or conflicts of interest that may affect the authors’ interpretation of the 
results?
27 (67.5) 3 (7.5) 10 (25.0)
20 Was ethical approval or consent of participants attained? 38 (95.0) 0 (0.0) 2 (5.0)
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after the adjustment for body mass, fasted levels of plasma 
leptin increased with age in a population of older women 
aged 67–78 years. It remains unclear whether older adults 
experience leptin resistance in association with increased 
circulating concentrations, as experienced by obese popu-
lations [28]. Consequently, understanding leptin sensitivity 
in older adults is important to appreciate whether elevated 
concentrations of this hormone exert an anorectic effect and 
whether leptin represents a therapeutic target for improving 
appetite outcomes in this population.
In accordance with the higher levels of leptin in older 
adults, fasted and postprandial insulin concentrations were 
also elevated. Circulating levels of insulin are determined 
primarily by peripheral insulin sensitivity [29] which along-
side leptin correlate with adiposity [30] and deliver infor-
mation on peripheral energy stores to the central nervous 
system. Although the primary role of insulin is related to 
metabolic regulation, it has also been shown to exert ano-
rectic effects by acting on the arcuate nucleus of the hypo-
thalamus to signal satiety and reduce food intake [31]. 
The observed increase in insulin may therefore contribute 
towards the attenuation of hunger in older adults observed 
in this review. However, as with leptin, insulin resistance of 
the hypothalamus may occur in older adults [32], thereby 
hindering the anorectic effects of this peptide. The rela-
tive importance of ageing and altered body composition as 
mediators of the increased insulin concentrations is unclear. 
The mean BMI value for younger (23.6 kg m−2) and older 
adults (24.8 kg m−2) was similar, suggesting that differences 
observed in insulin concentration are not a result of differ-
ences in weight status (as a proxy of body composition). 
In addition, despite differences in fasted insulin concentra-
tions between older and younger adults, mean fasted plasma 
glucose concentrations were similar at 5.3 mmol L−1 and 
5.0 mmol L−1, respectively, and suggested a healthy glucose 
tolerance in both groups. Additionally, mean HOMA-IR val-
ues for participants in the included studies were 1.67 for 
older adults and 1.57 for younger adults. Regardless, these 
findings highlight the need for interventions to reduce cir-
culating concentrations of insulin from both an appetite and 
metabolic health perspective.
The PYY findings from this meta-analysis demonstrated 
a strong trend towards statistical significance for higher 
postprandial concentrations in older versus younger adults. 
This effect was observed despite the inclusion of only four 
studies and the subsequent likelihood of the analysis being 
underpowered. Interestingly, out of the four included stud-
ies in the present review, Moss [33] and Di Francesco et al. 
[34] both showed significantly higher circulating concen-
trations of PYY in older adults following the ingestion of 
a test meal. However, following intraduodenal infusion of 
lipid and glucose [35] and whey protein [36], circulating 
postprandial PYY concentrations were comparable between 
younger and older adults. Consequently, the effects of age 
on PYY concentrations appear to be most prominent when 
nutrients are naturally ingested, thereby including mastica-
tion and swallowing, rather than directly reaching the distal 
gastrointestinal tract [37]. It is possible that the observed 
results in the present review support previous speculations 
that bypassing of the stomach during intraduodenal infusion 
may attenuate PYY release, thereby diminishing any poten-
tial appetite-regulatory effects [7]. Critically, the ingestion of 
food as standardised test meals reflects typical human eating 
behaviours which suggests that increased PYY concentra-
tions are likely to be experienced by older adults in response 
to habitual feeding. Unlike leptin and insulin, obesity does 
not seem to cause peripheral resistance to PYY [38–40], 
suggesting that the observed increases in older adults are 
likely to exert anorectic effects. The increased circulating 
PYY concentrations may further promote satiety by also 
contributing to reductions in gastric emptying rates in older 
adults [24].
Surprisingly, acylated ghrelin, total ghrelin, GLP-1 and 
GIP concentrations were not significantly different between 
older and younger adults in the present review. Alternatively, 
the differences in leptin, CCK, PYY and insulin appear to 
align with the reduction in hunger and energy intake in older 
adults observed in this meta-analysis. Consequently, it seems 
most beneficial for future interventions to target CCK, leptin, 
PYY and insulin when investigating methods to augment 
energy intake to reduce the anorexia of ageing from an endo-
crine perspective.
As a part of the present review, we extracted and analysed 
data for hunger perceptions and energy intake when meas-
ured alongside appetite-related hormones in the included stud-
ies. These findings mirror those of the recent meta-analysis 
by Giezenaar et al. [41] by demonstrating that energy intake 
was significantly lower in older adults than younger adults. 
However, in the present review, energy intake appeared to be 
moderated by the method of dietary assessment. Specifically, 
the results revealed that a difference in energy intake was only 
observed when self-report methods were used and not through 
researcher-assessed methods. It is apparent within the research 
literature that there is generalised underreporting when using 
self-report methods to assess energy intake. Therefore, our 
findings should be considered with caution as it is clear that 
limitations are present in self-report methods [42]. Nonethe-
less, the results indicate large decrease in fasted hunger in 
older adults compared with younger adults which is a known 
predictor for energy intake [43]. Postprandial hunger percep-
tions also tended to be lower in older adults than younger 
adults but with only a small effect size. In combination with 
differences in appetite-related hormone concentrations, these 
effects may also be mediated by diminished homeostatic regu-
lation of physiological functions in older adults. For example, 
older adults have been shown to experience delayed gastric 
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emptying rate, altered pyloric motility and increased antral 
area [34, 35, 44, 45].
In the current review, the hormones investigated which 
aligned with observed reductions in hunger and energy 
intake in older adults were CCK, leptin, insulin and PYY. 
It must be stressed that hormones involved in appetite regu-
lation are only one aspect of a complex system that regu-
lates feeding behaviour and that there may be other factors 
interacting which could also contribute to the changes in 
hunger and energy intake observed. Nevertheless, interven-
tions to reduce circulating concentrations of these anorectic 
hormones may be useful to oppose the anorexia of ageing.
Despite the important findings in the current meta-anal-
ysis, some notable limitations must be acknowledged. First 
the hormones PP, oxyntomodulin and fasted acylated ghrelin 
are known to be mediators of appetite regulation. However, 
these hormones could not be included in the analysis due to 
only one study meeting the criteria for fasted acylated ghre-
lin and the absence of any studies measuring oxyntomodulin 
or PP concentrations. The present study explored differences 
in appetite regulation in healthy older adults, and it is there-
fore appreciated that the findings cannot be generalised to 
older adults who possess underlying co-morbidities. It must 
also be noted that the presence of co-morbidities and tak-
ing medication amongst participants was reported in only 
22 studies, respectively. Consequently, the authors cannot 
be certain that all participants were free of underlying co-
morbidities and were not taking medication. Additionally, 
despite our extensive search retrieving 3103 records, we can-
not guarantee that our search was completely exhaustive of 
the relevant literature. However, having hand searched the 
reference lists of all included studies and review articles, 
we are confident that we have included all available relevant 
studies.
Conclusions
This meta-analysis reveals that circulating concentrations of 
insulin, leptin, CCK and PYY are increased in older adults. 
Given the anorectic effect of these appetite-related hor-
mones, such changes in older adults provides an underlying 
mechanism which may contribute towards the anorexia of 
ageing. Interventions to reduce circulating levels of these 
hormones may be beneficial for increasing appetite in older 
adults to attenuate, delay, or prevent the anorexia of ageing.
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